{"name":"Herbert DuPont, MD","slug":"herbert-dupont-md","ticker":"","exchange":"","domain":"","description":"Herbert DuPont, MD is a biotechnology company focused on developing innovative treatments in the field of microbiome therapy. The company's lead product, PRIM-DJ2727, is a Fecal Microbiota Transplantation (FMT) product currently in Phase 2 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQRDhWeUI3eENoYi1nS3duSnBhQWYyRktHcVdRbmdrcnVfejFqWDh2bFdUQm53Nm9VS1h1cXBVSVNrUklnSFdOWGhUWDBXNUlDcFptNlpXc0NGM3NOeWZFWWdFbEpXMkF6ZGJ0LVphN0lfOUl0dlh0UUNNRUhPNlhibG9oNE5UOGxWZ1JQaXlzdGxJaGphUFp6SA?oc=5","date":"2024-03-04","type":"pipeline","source":"Healio","summary":"Hooked on ID with Brad Perkins, MD, MBA - Healio","headline":"Hooked on ID with Brad Perkins, MD, MBA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNLXZKTGZmOEdFbUQ1UlZaUjFZVEI5VUpmLUNnRjk3eGJtZDM5TkhGQ2gzRDZhSWRLZmlxSWc5RkNvVWkzbG1XOE9NVkN4UmlZLVh0aGp3Um9QZDdTWE4zRXFIRHZOcHJXM2RVYVdlUFBQVmVPczNOcTQ5VzUtM2xScVVEZmN4QUtu?oc=5","date":"2018-11-19","type":"regulatory","source":"Medical Professionals Reference","summary":"FDA Approves New Treatment for Travelers’ Diarrhea - Medical Professionals Reference","headline":"FDA Approves New Treatment for Travelers’ Diarrhea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOQzFxTVdlY3Z5Z0NXeXB3TXdxN0N3b1VYaEIxQUQ2aEFmcUhjTGl5Q3RNY24xTFl3ai1raWZzSmg2RzZzMFlYTDBqdTJCX19adWZvZjZjNVg2cVhyR3FqVFE2eENIU0p0cDlLS3dJZ3pISUYzdWU0em5DVWhrZ3Z2THdoXzV4dWN3MkYwNkhzZThNY0xRaXV2QkRkSmZtcWlMQ2c?oc=5","date":"2017-03-16","type":"trial","source":"TMC Houston","summary":"UTHealth study paves the way for Clostridium difficile treatment in pill form - TMC Houston","headline":"UTHealth study paves the way for Clostridium difficile treatment in pill form","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE5jckNsblZURkZ5ZkhIWFpmV19vZXRFcnp1UlFOOUZOTVhjWkg0RmNRNnRGQ21LWGIzSjFJQmhjcVhwb1FWX0hrRXlWNXYwNmp1SnhrUGNBNHpsSlk?oc=5","date":"2013-10-11","type":"pipeline","source":"EurekAlert!","summary":"UTHealth's Cesar Arias earns infectious diseases award - EurekAlert!","headline":"UTHealth's Cesar Arias earns infectious diseases award - EurekAlert!","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}